Immunomedics Inc. (IMMU) had a good day on the market for Friday December 06 as shares jumped 11.3% to close at $20.59. About 5.49 million shares traded hands on 39,250 trades for the day, compared with an average daily volume of n/a shares out of a total float of 195.98 million. After opening the trading day at $18.75, shares of Immunomedics Inc. stayed within a range of $20.92 to $18.67.
With today’s gains, Immunomedics Inc. now has a market cap of $4.04 billion. Shares of Immunomedics Inc. have been trading within a range of $19.94 and $11.55 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company’s pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.
Immunomedics Inc. is based out of Morris Plains, NJ and has some 346 employees.
Immunomedics Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.